Chimerix Stock Quote
$2.50 -$0.04 -1.6%
BATS BZX Real Time Price as of August 16, 2019, 4:00 p.m. EDT View Interactive CMRX Charts

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.

News & Analysis: Chimerix


Market Moves

Why Chimerix Inc. Is Up Big Today

Shares are recovering today from their massive sell-off, but the company's near-term future remains a mystery.

Worst Small-Cap Stocks of 2015

Here's why a brand management company, a marine shipper, and a biopharmaceutical were the worst-performing small company stocks in 2015.

Why Chimerix's Shares Collapsed Today

The biopharma's shares imploded after the company's lead product candidate missed its primary endpoint in a late-stage study.

Why Chimerix, Inc. Shares Took Off

Chimerix shares rally following the close of its share offering. Find out what shareholders should have their eyes on instead.

Why Chimerix, Inc. Shares Flew Higher

Chimerix shares soar following a successful cash-raising effort. Find out what investors should really be watching with Chimerix going forward.

Interactive Chart